| Date | Time | Source | Headline | Symbol | Company |
| 07/07/2008 | 6:55PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2008 | 6:53PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2008 | 6:50PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2008 | 6:46PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2008 | 6:44PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2008 | 6:41PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2008 | 6:39PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2008 | 6:35PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/19/2008 | 4:08PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/11/2008 | 9:33AM | Marketwired | Wall Street News Alert: MEDP Is Wednesday's Stock to Watch! June 11, 2008 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2008 | 9:05AM | Marketwired | Story Stock for Tuesday, June 10, 2008: NPHS Value Added Service! | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2008 | 8:50PM | PR Newswire (US) | After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DUR | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2008 | 7:30PM | PR Newswire (US) | Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2008 | 12:56PM | Marketwired | BellwetherReport.com Analyst Report on TWTI, HOLX, AMLN and SOLF | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2008 | 10:40AM | PR Newswire (US) | Seven Summits Research Releases Comments on MCD, NUE, NEM, CF, and AMLN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2008 | 9:10AM | Marketwired | Stock on the Move for Monday: MEDP! June 9, 2008 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/07/2008 | 1:00PM | PR Newswire (US) | Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced I | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/07/2008 | 12:00PM | PR Newswire (US) | Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycem | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/06/2008 | 5:27PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/06/2008 | 5:23PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/06/2008 | 4:11PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/05/2008 | 6:30PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/03/2008 | 2:09PM | Marketwired | New Analyst Reports for OSI PHARMACEUTICALS INC, CITRIX SYSTEMS INC, AMYLIN PHARMACEUTICALS INC, and IMCLONE SYSTEMS INCORPORATE | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/03/2008 | 1:24PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/02/2008 | 6:04PM | PR Newswire (US) | Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/02/2008 | 12:46PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/30/2008 | 6:18PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/30/2008 | 4:11PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/23/2008 | 7:00PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/22/2008 | 5:26PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |